Mohamed Genead
Vorstandsvorsitzender bei Aviceda Therapeutics, Inc.
Aktive Positionen von Mohamed Genead
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Gründer | - | - | |
| Präsident | - | - | |
| Unternehmenssekretär | - | - | |
| Treasurer | - | - | |
Aviceda Ophthalmics, Inc.
 Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Vorstandsvorsitzender | - | - |
| Vorsitzender | - | - | |
| Finanzdirektor/CFO | - | - | |
| Präsident | - | - | |
| Unternehmenssekretär | - | - |
Karriereverlauf von Mohamed Genead
Ehemalige bekannte Positionen von Mohamed Genead
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2017 | 01.11.2017 |
| University of Illinois | Corporate Officer/Principal | - | - |
| OCUGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Statistik
International
| Vereinigte Staaten | 5 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Börse
- Insiders
- Mohamed Genead
- Erfahrung
